First Trust Advisors’s Puma Biotechnology PBYI Stock Holding History

First Trust Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Buy	130,206 +6,693	+5%	+$49K	﹤0.01%	2210
2026 Q1	$789K	Buy	123,513 +713	+0.6%	+$4.6K	﹤0.01%	2236
2025 Q4	$731K	Buy	122,800 +3,021	+3%	+$16K	﹤0.01%	2251
2025 Q3	$636K	Buy	+119,779	New	+$508K	﹤0.01%	2255
2019 Q3	–	Sell	-50,987	Closed	-$648K	–	2456
2019 Q2	$648K	Buy	+50,987	New	+$1.17M	﹤0.01%	2022
2017 Q4	–	Sell	-4,586	Closed	-$549K	–	2446
2017 Q3	$549K	Buy	+4,586	New	+$427K	﹤0.01%	2053

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors's PBYI Position: Q2 2026 in Review

First Trust Advisors increased its Puma Biotechnology (PBYI) stake by 5.4% in Q2 2026, buying an estimated $49K and bringing the position to 130,206 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2210.

First Trust Advisors first reported a position in PBYI in Q3 2017 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

First Trust Advisors held 130,206 shares of Puma Biotechnology worth $1.06M as of Q2 2026.
First Trust Advisors bought 6,693 Puma Biotechnology shares in Q2 2026, an estimated $49K.
Puma Biotechnology made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2210 holding.
First Trust Advisors first reported a position in Puma Biotechnology in Q3 2017 and has held it in 6 quarters since.
161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.